[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"stock-detail-LIMN":3,"homepage-market-summary":30,"stock-news-LIMN":171},{"ticker":4,"date":5,"profile":6,"dividend":9,"quote":15},"LIMN","2026-10-05",{"name":7,"exchange":8,"sector":9,"industry":10,"description":11,"ceo":9,"employees":12,"headquarters":13,"founded":9,"is_fund":14,"issuer":9,"category":9},"Liminatus Pharma, Inc. Class A Common Stock","Nasdaq",null,"BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)","Liminatus Pharma Inc is a clinical-stage biopharmaceutical company engaged in developing cancer therapies and treatments. The company is developing a next generation CD47 immune checkpoint inhibitor that enables cancer cells to evade detection by the immune system. Anti-CD47 monoclonal antibodies generally induce anemia and thrombocytopenia due to their binding to red blood cells and platelets. The Liminatus CD47 mAb has shown to preferentially bind to immune cells, but not to red blood cells and platelets and does not induce hemolysis. The clinical candidate is currently in the late preclinical stage.","1","Cerritos, CA",false,{"close":16,"open":17,"high":18,"low":17,"prev_close":19,"change":20,"percent_change":21,"volume":22,"transactions":23,"vwap":24,"high_52w":25,"low_52w":26,"avg_volume_52w":27,"range_52w_percent":28,"record_count":29},3.99,3.8,4.08,3.9,0.09,2.31,17784.20051,523,3.9819,5.8756,0.094999999,13099693.164053777,67.4,359,{"status":31,"indices":32,"watchlist":75,"sectors":97,"benchmarks":151},"success",[33,41,48,55,62,68],{"symbol":34,"name":35,"price":36,"change":37,"pct_change":38,"is_up":39,"sparkline":40,"date":5},"SPX","S&P 500",7773.95,51.23,0.66,true,"0.0,8.3 2.3,10.7 4.6,13.5 6.9,9.4 9.3,11.7 11.6,13.9 13.9,16.0 16.2,10.6 18.5,9.8 20.8,2.6 23.2,2.6 25.5,6.3 27.8,6.4 30.1,3.9 32.4,7.7 34.7,8.5 37.1,9.7 39.4,8.8 41.7,5.2 44.0,2.0",{"symbol":42,"name":43,"price":44,"change":45,"pct_change":46,"is_up":39,"sparkline":47,"date":5},"NDX","NASDAQ 100",31076.44,268.51,0.87,"0.0,12.3 2.3,12.8 4.6,14.9 6.9,13.2 9.3,14.8 11.6,16.0 13.9,16.0 16.2,12.7 18.5,11.4 20.8,5.9 23.2,4.3 25.5,6.0 27.8,5.9 30.1,5.1 32.4,7.2 34.7,6.8 37.1,6.4 39.4,5.8 41.7,3.8 44.0,2.0",{"symbol":49,"name":50,"price":51,"change":52,"pct_change":53,"is_up":39,"sparkline":54,"date":5},"DJI","DOW JONES",51268,91,0.18,"0.0,2.0 2.3,5.0 4.6,7.4 6.9,3.6 9.3,4.7 11.6,7.2 13.9,11.9 16.2,9.5 18.5,10.2 20.8,7.5 23.2,8.9 25.5,11.5 27.8,12.7 30.1,9.1 32.4,11.7 34.7,12.7 37.1,16.0 39.4,15.8 41.7,14.0 44.0,13.3",{"symbol":56,"name":57,"price":58,"change":59,"pct_change":60,"is_up":39,"sparkline":61,"date":5},"COMP","NASDAQ Composite",27477.31,286.45,1.05,"0.0,11.9 2.3,13.4 4.6,15.0 6.9,12.7 9.3,14.1 11.6,16.0 13.9,16.0 16.2,11.9 18.5,10.9 20.8,5.3 23.2,4.2 25.5,7.1 27.8,7.0 30.1,5.8 32.4,8.1 34.7,8.3 37.1,7.8 39.4,7.7 41.7,4.7 44.0,2.0",{"symbol":63,"name":64,"price":65,"change":66,"pct_change":38,"is_up":39,"sparkline":67,"date":5},"RUT","RUSSELL 2000",2833.8,18.6,"0.0,2.0 2.3,5.4 4.6,7.8 6.9,6.8 9.3,8.3 11.6,10.0 13.9,11.0 16.2,9.7 18.5,10.8 20.8,9.6 23.2,8.2 25.5,12.6 27.8,12.9 30.1,12.6 32.4,14.2 34.7,15.1 37.1,16.0 39.4,15.1 41.7,13.0 44.0,11.4",{"symbol":69,"name":70,"price":71,"change":72,"pct_change":73,"is_up":39,"sparkline":74,"date":5},"VIX","CBOE VIX",15.52,0.21,1.37,"0.0,10.2 2.3,7.3 4.6,2.0 6.9,9.7 9.3,4.9 11.6,4.5 13.9,2.5 16.2,11.3 18.5,13.7 20.8,13.5 23.2,16.0 25.5,12.3 27.8,10.4 30.1,13.5 32.4,8.8 34.7,8.9 37.1,7.8 39.4,7.6 41.7,11.8 44.0,10.9",[76,83,90],{"symbol":77,"name":78,"price":79,"change":80,"pct_change":81,"is_up":39,"sparkline":82,"date":5},"NVDA","NVIDIA Corp",238.9,4.95,2.12,"0.0,16.0 7.3,12.2 14.7,13.8 22.0,12.6 29.3,10.1 36.7,7.0 44.0,2.0",{"symbol":84,"name":85,"price":86,"change":87,"pct_change":88,"is_up":14,"sparkline":89,"date":5},"AAPL","Apple Inc",332.89,-0.8,-0.24,"0.0,2.0 7.3,5.2 14.7,16.0 22.0,11.7 29.3,14.9 36.7,10.9 44.0,11.8",{"symbol":91,"name":92,"price":93,"change":94,"pct_change":95,"is_up":39,"sparkline":96,"date":5},"TSLA","Tesla Inc",378.69,8.1,2.18,"0.0,5.6 7.3,13.5 14.7,16.0 22.0,14.9 29.3,15.3 36.7,6.4 44.0,2.0",[98,103,108,113,118,123,128,132,137,142,146],{"name":99,"etf":100,"change":101,"price":102,"is_up":39},"Technology","XLK",0.56,200.93,{"name":104,"etf":105,"change":106,"price":107,"is_up":39},"Financials","XLF",0.73,53.88,{"name":109,"etf":110,"change":111,"price":112,"is_up":39},"Healthcare","XLV",0.72,167.37,{"name":114,"etf":115,"change":116,"price":117,"is_up":39},"Consumer Cycl","XLY",0.35,110.42,{"name":119,"etf":120,"change":121,"price":122,"is_up":39},"Consumer Staples","XLP",0.63,81.04,{"name":124,"etf":125,"change":126,"price":127,"is_up":39},"Energy","XLE",0.99,63.44,{"name":129,"etf":130,"change":20,"price":131,"is_up":39},"Industrials","XLI",170.1,{"name":133,"etf":134,"change":135,"price":136,"is_up":39},"Materials","XLB",1.31,49.5,{"name":138,"etf":139,"change":140,"price":141,"is_up":14},"Real Estate","XLRE",-0.34,40.67,{"name":143,"etf":144,"change":116,"price":145,"is_up":39},"Utilities","XLU",39.97,{"name":147,"etf":148,"change":149,"price":150,"is_up":39},"Comm Services","XLC",1.17,111.61,[152,157,162,167],{"ticker":153,"name":154,"price":155,"change":156,"is_up":39},"SPY","SPDR S&P 500 ETF",774.83,0.67,{"ticker":158,"name":159,"price":160,"change":161,"is_up":39},"QQQ","Invesco QQQ Trust",756.2,0.88,{"ticker":163,"name":164,"price":165,"change":166,"is_up":39},"DIA","SPDR Dow Jones ETF",512.11,0.2,{"ticker":168,"name":169,"price":170,"change":38,"is_up":39},"IWM","iShares Russell 2000",283.39,{"ticker":4,"count":172,"articles":173},5,[174,180,186,191,197],{"title":175,"link":176,"pubDate":177,"description":178,"source":179},"Liminatus Pharma Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi3AFBVV95cUxPTzVuaGFVdzZ5YmdDWHhjWTU4TDVMdlg3VFJEQ1JwWVlBMVQ4d3RCSVNUbWttbnB2RE5tTjBLaUNlREhpWW50dVp2MW9vYnVMeFAxLUd4aUxZR3dFTkNJTUwwNDBrYUY4TXB2LUtTVWdpZ3pCQ2p6YWw1bWNPYlNDeXJCa1dnTnVVY1l3T3JiaW5SN19iQU5SaU83ejlReFFncUExYjVnMi1LYlVfUGl0OTE2ZDRiUllfTHRxSTMwNUYxWlBETTNEcVAwVTh5SkRacDhLbklIQzdpT19F?oc=5","Tue, 29 Sep 2026 13:23:00 GMT","Liminatus Pharma Disclosed Failure to Satisfy a Continued Listing Rule or Standard TradingView","TradingView",{"title":181,"link":182,"pubDate":183,"description":184,"source":185},"Form 8K Liminatus Pharma Inc Class A For: 29 September By Investing.com - Investing.com Nigeria","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMitAFBVV95cUxPSjhwRHRHNW1HU1kwYUIxd21mOVJCbUZaZjZzOE04bUY3b2JLLWNHNHgwNkNRSS0zdzd3UXRFSU1RYTNSSU0zbkktLTZaWGQ3ZmppT2xyWDBvM3ppaS16ZlZxaXgwTWJpOTY0Zkl6d0o5emwtbFlacnhfSGg1YVlWcXc5OXBWTUMwNUVwc0hHY25jWDhwbkFoc2w2VzU3Y1AzMWp6YlplWEwwcFJCMmVFRzdubi0?oc=5","Tue, 29 Sep 2026 14:55:33 GMT","Form 8K Liminatus Pharma Inc Class A For: 29 September By Investing.com Investing.com Nigeria","Investing.com Nigeria",{"title":187,"link":188,"pubDate":189,"description":190,"source":179},"Liminatus Pharma regains Nasdaq compliance - TradingView","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiqAFBVV95cUxQRXJ2TkVzTDhtWFRvUjJyZnRWOWRHX0RWZnlIakhJTjE4dGd5UGV4T1FpSmFCQkVQX0F2Z2dUeHdGT2ZITS1PcDBfWGg2YUl5WVV5T3UxbmFaVmkwYXMzamFoUFNfcWxfa1VVd3lsUjdkTEItempsWEFRcTVjTnppSm9OR3BkX0pFVVRkR09QYjAwbFhNSUNsaGc2YkRMdmpBQ1ZuLU92Wk8?oc=5","Tue, 29 Sep 2026 13:36:01 GMT","Liminatus Pharma regains Nasdaq compliance TradingView",{"title":192,"link":193,"pubDate":194,"description":195,"source":196},"Liminatus Pharma regains Nasdaq minimum bid price compliance - Investing.com India","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMivgFBVV95cUxPcFFMMXBnRkp1Z1BLaWxRSkZVMDcwWEhleHExTlRnbUpwMWFMYmhvd3ktTW9ISGdFSW4tRDdZMl9oeUdWSC1kWGFKRGdZSzZEcjl1aTR3SnBiT0RCS3ZWZGtOMGZYRFhWOWpVZ0pzQVlQSEFoYkswM3RTUXNaM2pEZGd3eVRQTUN2bUtLTWZGS2gzTTEwdDZlUEcyWFRkOUxLdkFpNEJpenl2Zmc3TTk4MGN0cEhtYWlxM0dqNFZB?oc=5","Tue, 29 Sep 2026 13:20:37 GMT","Liminatus Pharma regains Nasdaq minimum bid price compliance Investing.com India","Investing.com India",{"title":198,"link":199,"pubDate":200,"description":201,"source":202},"Liminatus Pharma Regains Nasdaq Compliance After Reverse Split - TipRanks","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMitAFBVV95cUxNWmJGNS1IYlNWNU5tOWpPdU96R0pjbTJIeGQ0TF9vaXVaQTJPTW5iQ0VDX2pZajd2bE44WHpKQnUyWjhHMzFzT3NtWnA4MnFfcEJDaUx1QzNUTldnMjI0TEVaMlBqMVFaOE9iX1JNYTZSRXI3dDJfSzNpdmkwWjB6cVhoREVhUGloM3Qzd2NmUzRxakVkQy01QXhvcWRsd1c2T0NEaVhwQnBuY2h2M2RYVndMckI?oc=5","Tue, 29 Sep 2026 14:15:15 GMT","Liminatus Pharma Regains Nasdaq Compliance After Reverse Split TipRanks","TipRanks"]